2020
DOI: 10.1016/j.jconrel.2020.01.051
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
32
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 47 publications
(32 citation statements)
references
References 49 publications
0
32
0
Order By: Relevance
“…A consistent pattern of elevated cytokines accompanied by increased prevalence of CD8+ T cell in US treated tumor tissue hints to a hallmark signaling cascade for “cold‐to‐hot” tumor transition. In one of our recent work, we reported such immunomodulatory effects in mouse xenograft HCC tumor treated with similar strategy [ 63 ] (Figure 5). With growing evidence along this line, exploiting antitumoral immune effects could enhance the therapeutic efficacy of the proposed combination therapy for HCC.…”
Section: Resultsmentioning
confidence: 63%
See 1 more Smart Citation
“…A consistent pattern of elevated cytokines accompanied by increased prevalence of CD8+ T cell in US treated tumor tissue hints to a hallmark signaling cascade for “cold‐to‐hot” tumor transition. In one of our recent work, we reported such immunomodulatory effects in mouse xenograft HCC tumor treated with similar strategy [ 63 ] (Figure 5). With growing evidence along this line, exploiting antitumoral immune effects could enhance the therapeutic efficacy of the proposed combination therapy for HCC.…”
Section: Resultsmentioning
confidence: 63%
“…This observation is consistent with our earlier study, where we reported that US targeted MB destruction in HCC mouse xenografts triggered a 189 ± 33% increase in TNF‐α (in 0.5 h post treatment). [ 63 ] Since TNF‐α is an inflammatory cytokine predominantly secreted by activated leukocytes in blood stream, and it is plausible that the observed surge in TNF‐α is an outcome of US‐MB treatment mediated recruitment and activation of leucocytes in HCC. The recruitment of tumor infiltrating leukocytes (T lymphocyte) in the tumor milieu primes the switch from “cold” HCC tumor into “hot” tumor to augment therapeutic miRNA combination therapy against HCC.…”
Section: Resultsmentioning
confidence: 99%
“…We also observed in our earlier study that immune cytokines levels are significantly altered upon US‐MB mediated delivery of miRNA loaded PLGA‐PEG NPs. [ 31 ] Hence, we chose immunocompetent BALB/c mice to establish 4T1 syngeneic tumor for evaluation of therapeutic efficacy in this study. The study was designed to evaluate two different hypotheses: 1) US‐MB treatment improves delivery of TK‐p53‐NTR and/or miRNAs into the tumor, and 2) to evaluate miRNA combination therapy improves therapeutic outcome of TK‐p53‐NTR suicide gene therapy in the presence of prodrugs.…”
Section: Resultsmentioning
confidence: 99%
“…114 Ultrasound-targeted microbubble destruction (UTMD)− miRNA combination therapy, which uses UTMD for local delivery of nanoparticle-loaded miRNA-122 and anti-miRNA-21, alters the immune microenvironment in Hepa1-6 tumors by modulating cytokine expression, improving the response of HCC to chemotherapy by eliminating drug resistance. 115 Triple-action nanoparticles acting via CXCR4 antagonism and miR-210/KRAS G12D downregulation improved pancreatic cancer therapeutic effects, as revealed by delayed tumor growth, stromal depletion, reduced immunosuppression, inhibited metastasis, and prolonged survival. 116 In addition to nanoparticle-based delivery, an RNA micelle platform can be used to deliver anti-miRNA agents.…”
Section: Mir-451mentioning
confidence: 99%